JAN 20, 2022 5:15 PM PST

Review Finds Improved Transparency Among Antidepressant Drug Trials

WRITTEN BY: Annie Lennon

Trials relating to newly developed antidepressant drugs are becoming more transparent. The corresponding study was published in PLOS Medicine by researchers at the Oregon Health & Science University. 

The present research is a follow-up of a 2008 study that found that 31% of studies viewed by the Food and Drug Administration (FDA) related to antidepressant drugs were not published. Many of these studies showed negative results for antidepressant drugs on mental health. 

This meant that, according to published literature at the time, 94% of antidepressant trial results appeared to be positive; however, when taking the unpublished studies into account, just 51% remained positive. 

For the present study, the researchers compared data from published reports on antidepressants from 2008 to 2013 with a previously published dataset of trials between 1987 and 2002. Between 2008 and 2013, the researchers identified 30 clinical trials. Of these, 15 studies presented negative results. While eight were either unpublished or misrepresented in the scientific literature, the remaining seven- or 47%- were transparently reported. 

While still far from 100%, the researchers say that this is still an improvement, given that among the studies analyzed from between 1987 and 2002, just 11% of negative studies were reported transparently. This improvement, say the researchers, stems from numerous policy changes aimed at transparency as well as a cultural change in what is considered ‘standard practice’. 

"Doctors prescribe based upon what the drug companies choose to publish, which can be a cherry-picked version of the full story," said lead author of the study, Erick Turner, M.D.,"By hiding negative trial results and selectively publishing only positive results, drugs will look more effective than they actually are. Doctors need to be made aware of all trial results -- positive and negative -- so they can be fully informed when they prescribe drugs for their patients.

"Fortunately, we are seeing progress," he said. "Negative studies, once a dirty little secret, are now being acknowledged more often. The dark era of opacity appears to be in the rear-view mirror, but much work lies ahead if we are going to see full transparency.

Sources: PLOS Medicine, Science Daily

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 13, 2022
Microbiology
Creating a foundation for change: A tangible strategy to fight AMR
APR 13, 2022
Creating a foundation for change: A tangible strategy to fight AMR
Apply the learnings of COVID to AMR, says coalition Tackling the deadly spectre of antimicrobial resistance (AMR) requir ...
APR 15, 2022
Drug Discovery & Development
First Drug for Sleep Apnea Shows Promise in Patients
APR 15, 2022
First Drug for Sleep Apnea Shows Promise in Patients
A new drug for sleep apnea could reduce breathing pauses during sleep by over 20 per hour. The corresponding study was p ...
APR 28, 2022
Genetics & Genomics
A Genetic Cause of Lupus is Identified
APR 28, 2022
A Genetic Cause of Lupus is Identified
Lupus is an autoimmune disease that can impact anyone, but tends to affects women between the ages of 15 and 45. The dis ...
APR 28, 2022
Health & Medicine
Antidepressants Not Associated Improved Quality of Life
APR 28, 2022
Antidepressants Not Associated Improved Quality of Life
According to a recently published study in PLoS, antidepressants do not improve health-related quality of life (HRQoL) o ...
MAY 06, 2022
Drug Discovery & Development
Scientists discover new methods of production for Sulphur-based medications
MAY 06, 2022
Scientists discover new methods of production for Sulphur-based medications
Modern medicine has drastically changed since humans discovered the first ancient treatment methods. Herbal remedies and ...
MAY 19, 2022
Drug Discovery & Development
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
MAY 19, 2022
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
Eastern equine encephalitis virus (EEEV), Western equine encephalitis (WEEV), Venezuelan equine encephalitis (VEEV) are ...
Loading Comments...